CIK: 0001634557
Total reported value
—
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ABBV | Abbvie INC | Stock-Healthcare | 33.86% | — | +1.84% | |
| 2 | PRTA | Prothena Corporation plc | Stock-Other | 24.42% | — | +0.09% | |
| 3 | ALKS | Alkermes plc | Stock-Healthcare | 19.94% | — | -1.30% | |
| 4 | TBPH | Theravance Biopharma, Inc. | Stock-Other | 16.13% | -71.30% | EXIT | |
| 5 | BIIB | Biogen INC | Stock-Healthcare | 3.13% | — | +45.83% | |
| 6 | GILD | Gilead Sciences INC | Stock-Healthcare | 2.12% | — | +26.19% | |
| 7 | NWBO | Northwest Biotherapeutics | Stock-Other | 0.42% | — | -4.25% |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | ABBV | Abbvie INC | +5.7% | +1.84% | Add |
| 2 | ALKS | Alkermes plc | +5.6% | -1.30% | Trim |
| 3 | TBPH | Theravance Biopharma, Inc. | +2.4% | +11.70% | Add |
| 4 | BIIB | Biogen INC | +1% | +45.83% | Add |
| 5 | GILD | Gilead Sciences INC | +0.6% | +26.19% | Add |
| 6 | NWBO | Northwest Biotherapeutics | -0.2% | -4.25% | Trim |
| 7 | PRTA | Prothena Corporation plc | -0.5% | +0.09% | Add |
| 8 | REYN | Reynolds Consumer Products Inc. | — | EXIT | Sold out |